Home › Funds › Bollard Group LLC › BSX
Bollard Group LLC position in BSX
BOSTON SCIENTIFIC CORP · Health Care
Bollard Group LLC reported holding 18,420,720 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q2 2026 13F filing — a position valued at US$786.2M, representing 25.78% of its reported portfolio and ranking #1 among its reported holdings. Bollard Group LLC has disclosed BSX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Bollard Group LLC's BSX position evolved
Bollard Group LLC first disclosed a stake in BSX in Q3 2023 at 23,344,726 shares (US$1.23B). The position peaked in Q2 2025 at 20,079,443 shares, worth US$2.16B. Across 12 filings, Bollard Group LLC increased the stake 0 time(s), trimmed it 11 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 18,420,720 shares valued at US$786.2M — a reduction of -111,453 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 23.34M | $1.23B | New |
| Q4 2023 | 22.39M | $1.29B | Reduce |
| Q1 2024 | 22.00M | $1.51B | Reduce |
| Q2 2024 | 21.66M | $1.67B | Reduce |
| Q3 2024 | 21.24M | $1.78B | Reduce |
| Q4 2024 | 20.73M | $1.85B | Reduce |
| Q1 2025 | 20.49M | $2.07B | Reduce |
| Q2 2025 | 20.08M | $2.16B | Reduce |
| Q3 2025 | 19.73M | $1.93B | Reduce |
| Q4 2025 | 19.00M | $1.81B | Reduce |
| Q1 2026 | 18.53M | $1.16B | Reduce |
| Q2 2026 | 18.42M | $786.20M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 19 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- Banque Cantonale Vaudoise 67.61K sh · $2.89B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 50.52M sh · $2.16B · Q2 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
More on Bollard Group LLC
FAQ
How long has Bollard Group LLC held BSX?
Bollard Group LLC has disclosed BSX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Bollard Group LLC's current position in BSX?
As of Q2 2026, Bollard Group LLC holds 18.42M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $786.20M, representing 25.78% of its reported portfolio and ranking #1.
Has Bollard Group LLC been buying or selling BSX?
In the latest 13F filing (Q2 2026), Bollard Group LLC reduced its position in BSX. The position peaked in Q2 2025 at 20.08M shares.
Which other funds hold BSX?
Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.